Iridium catalyst activates chemotherapy drug directly at targeted cancer cells
The Quick Take
Conventional chemotherapy treatments often attack not only cancer cells but also healthy tissue, leading to severe side effects such as hair loss or nausea. The team led by Dr. Thomas Ward from the Department of Chemistry and the Swiss Nanoscience Institute (SNI) at the University of Basel is therefore pursuing an approach that uses artificial metal compounds as catalysts that specifically bind to
Ground Level News aggregates headlines from public feeds. This page shows a short summary only; the full article and all rights belong to Phys.org - latest science and technology news stories.
Related
Science
Silk microneedles offer new way to deliver vaccines to farmed fish
Fish that are cultivated in pools or ponds are an increasingly important source of food around the world. Unfortunately, disease outbreaks can cause…
Science
Oldest recordings of Louisiana Creole discovered in Indiana archive
The language was already endangered when Black linguist Lorenzo Dow Turner documented its speakers in 1935. The post Oldest recordings of Louisiana Creole…
Science
Oil-producing yeast reveals two stages of fat accumulation under nitrogen limitation
A research team led by professors Xu Guowang and Liu Xinyu from the Dalian Institute of Chemical Physics (DICP) of the Chinese Academy of Sciences (CAS), in…
Science
Mapping Kīlauea's magma reservoirs at high resolution
The Hawaiian volcano Kīlauea is among the most active on Earth. Not only did it erupt almost continuously from 1983 to 2018, but it also began a new series of…